FROM THE LABORATORY TO THE HOME OF THE PATIENT INFECTED WITH ONCHOCERCA-VOLVULUS (O-V) - CLINICAL-EXPERIENCE WITH AMOCARZINE (PRELIMINARY-RESULTS)

Authors
Citation
Aa. Poltera, FROM THE LABORATORY TO THE HOME OF THE PATIENT INFECTED WITH ONCHOCERCA-VOLVULUS (O-V) - CLINICAL-EXPERIENCE WITH AMOCARZINE (PRELIMINARY-RESULTS), Parasite, 1, 1994, pp. 25-27
Citations number
4
Categorie Soggetti
Parasitiology
Journal title
ISSN journal
1252607X
Volume
1
Year of publication
1994
Supplement
1
Pages
25 - 27
Database
ISI
SICI code
1252-607X(1994)1:<25:FTLTTH>2.0.ZU;2-U
Abstract
if dosed correctly, amocarzine has onchocercacidal effects with accept able clinical tolerobility. Up to now over 1 900 patients were exposed to an initial amocarzine regimen and over 500 have been re-exposed to amocarzine 2 years after initial therapy Amocarzine is a promising on chocercacidal drug and a potential candidate for onchocerciasis contro l programmes.